Tricin 7-glucoside protects against experimental cerebral ischemia by reduction of NF-κB and HMGB1 expression
Authors:
- Yong XuYXYong Xu
- Shu-Ping ZhangSZShu-Ping Zhang
- Hai-Bo ZhuHZHai-Bo Zhu
- Jian HouJHJian Hou
- 1 January 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 45 (1-2) , 50-57
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Inhibition of nuclear factor-κB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusionJournal of Neuroinflammation, 2010
- Inhibitor of NF-κB Kinases α and β Are Both Essential for High Mobility Group Box 1-Mediated ChemotaxisThe Journal of Immunology, 2010
- High-Mobility Group Protein Box-1 and its Relevance to Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusionJournal of Neuroscience Methods, 2009
- HMG chromosomal proteins in development and diseaseTrends in Cell Biology, 2007
- T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neuronsNeurochemistry International, 2006
- Inflammation et accident ischémique cérébral aigu. Données actuelles et perspectivesRevue Neurologique, 2005
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats.Stroke, 1992